Highly profitable health care stocks are a hit with mutual fund investors. Innovative drugs, mergers and even ObamaCare are fueling the likes of Actavis (ACT), Centene (CNC) and Akorn (AKRX). That momentum grew in May. Health and biotech funds spiked 7.5% on average — topping all other domestic and foreign categories. Ten health care mutual funds beat that average.